Le Prix Nobel 2012, Shinya Yamanaka, visite le laboratoire I-Stem, pionnier en France des recherches sur les cellules souches

Press release – Inserm press room Le Prix Nobel 2012, Shinya Yamanaka, visite le laboratoire I-Stem, pionnier en France des recherches sur les cellules souches Link : https://presse.inserm.fr/en/le-prix-nobel-2012-shinya-yamanaka-visite-le-laboratoire-i-stem-pionnier-en-france-des-recherches-sur-les-cellules-souches/5195/

Other contents In the same category :

Institutional and special event Voir tout

2022 Inserm Prizes: Forming a Common Front for Our Health

This year, the Inserm Prizes are awarded to five individuals whose results and commitment to high-quality research demonstrate scientific excellence and the Institute's central place in society. The Inserm 2022 Grand Prize goes to Olivier Delattre, an oncopediatrician whose work has led ...

Inserm and CNRS to Lead Large-Scale Program on Psychiatry Research

On July 18, 2022, France’s minister for Higher Education and Research Sylvie Retailleau announced an unprecedented psychiatry research effort in the form of 80 million euros allocated over five years to the precision-psychiatry project-program PROPSY, led by Inserm and CNRS as part ...

Medias

Press Contact

AFM-Téléthon Anne-Sophie Midol, Stéphanie Bardon, Géraldine Broudin Tél : 01 69 47 28 28 / 06.45.15.95.87 / presse@afm.genethon.fr

Le Prix Nobel 2012, Shinya Yamanaka, visite le laboratoire I-Stem, pionnier en France des recherches sur les cellules souches

Other contents In the same category :

2022 Inserm Prizes: Forming a Common Front for Our Health

Inserm and CNRS to Lead Large-Scale Program on Psychiatry Research

Press Contact

A Common Food Additive Found to Alter the Human Microbiota and Intestinal Environment

COVID-19: How Does SARS-CoV-2 Infection Affect Vascular Irrigation of the Brain?

Les vaccins à ARNm susceptibles de modifier notre génome, vraiment ?

Troisième dose de vaccin anti-Covid, quelles sont les données ?